Person—dyslipidaemia treatment with anti-lipid medication indicator (current), code N
Data Element Attributes
Identifying and definitional attributes | |
Metadata item type: | Data Element |
---|---|
Short name: | Dyslipidaemia treatment indicator |
METEOR identifier: | 302440 |
Registration status: | Health!, Standard 21/09/2005 |
Definition: | Whether a person is being currently treated for dyslipidaemia using anti-lipid medication, as represented by a code. |
Data element concept attributes | |
Identifying and definitional attributes | |
Data element concept: | Person—dyslipidaemia treatment with anti-lipid medication indicator |
---|---|
METEOR identifier: | 304485 |
Registration status: | Health!, Standard 21/09/2005 |
Definition: | Whether an individual is being treated for dyslipidaemia (abnormal lipid levels) using anti-lipid medication. |
Object class: | Person |
Property: | Dyslipidaemia treatment with anti-lipid medication indicator |
Source and reference attributes | |
Submitting organisation: | National Diabetes Data Working Group |
Value domain attributes | |
Identifying and definitional attributes | |
Value domain: | Yes/no/not stated/inadequately described code N |
---|---|
METEOR identifier: | 301747 |
Registration status: | Health!, Standard 21/09/2005 Housing assistance, Standard 10/02/2006 Community Services (retired), Standard 14/02/2006 Early Childhood, Standard 21/05/2010 Homelessness, Standard 23/08/2010 Independent Hospital Pricing Authority, Standard 01/11/2012 Disability, Standard 07/10/2014 Indigenous, Standard 13/03/2015 Children and Families, Standard 22/11/2016 |
Definition: | A code set representing 'yes', 'no' and 'not stated/inadequately described'. |
Representational attributes | ||
Representation class: | Code | |
---|---|---|
Data type: | Number | |
Format: | N | |
Maximum character length: | 1 | |
Value | Meaning | |
Permissible values: | 1 | Yes |
2 | No | |
Supplementary values: | 9 | Not stated/inadequately described |
Collection and usage attributes | |
Guide for use: | CODE 9 Not stated/inadequately described This code is not for use in primary data collections. |
---|
Data element attributes | |
Collection and usage attributes | |
Guide for use: | CODE 1 Yes CODE 2 No |
---|---|
Collection methods: | Ask the individual if he/she is currently treated with anti-lipid medication. Alternatively obtain the relevant information from appropriate documentation. |
Source and reference attributes | |
Submitting organisation: | National diabetes data working group |
Origin: | National Diabetes Outcomes Quality Review Initiative (NDOQRIN) data dictionary. |
Relational attributes | |
Related metadata references: | Supersedes Person—dyslipidaemia treatment status (anti-lipid medication), code N Health!, Superseded 21/09/2005 |
Implementation in Data Set Specifications: | Acute coronary syndrome (clinical) DSS Health!, Superseded 01/09/2012 Acute coronary syndrome (clinical) DSS Health!, Superseded 02/05/2013 Acute coronary syndrome (clinical) NBPDS 2013- Health!, Standard 02/05/2013 Implementation start date: 01/07/2013 Diabetes (clinical) NBPDS Health!, Standard 21/09/2005 DSS specific information: Dyslipidaemia is associated with many health problems including diabetes and hypertension. It is often related to overweight and obesity. Usually caused by inappropriate diet and sedentary lifestyle, dyslipidaemia has been reaching epidemic proportions. Active lifestyle and low calorie diets are the best way of prevention, however sometimes for the treatment of dyslipidaemia the use of pharmacotherapy is required. Abnormal levels of blood lipids are associated with increased risk of developing CHD especially in diabetic patients. The risk of coronary and other macrovascular disorders is 2-5 times higher in people with diabetes than in non-diabetic subjects and increases in parallel with the degree of dyslipidaemia. Diabetes mellitus greatly modifies the significance of lipoprotein levels, particularly when associated with smoking, hypertension and family history of CVD. Poor metabolic control of diabetes seems to have impact on abnormal lipoprotein level. Primary dyslipidaemia, due to genetic and environmental (especially dietary) factors, is diagnosed if secondary causes have been excluded (hypothyroidism, nephrotic syndrome, cholestasis, anorexia nervosa, diabetes mellitus Type 2, renal impairment). |